4KB7 image
Deposition Date 2013-04-23
Release Date 2013-05-08
Last Version Date 2024-03-13
Entry Detail
PDB ID:
4KB7
Title:
HCV NS5B GT1B N316Y with CMPD 32
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.85 Å
R-Value Free:
0.24
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:HCV Polymerase
Mutations:L47Q, F101Y, K114R, N316Y
Chain IDs:A, B
Chain Length:580
Number of Molecules:2
Biological Source:Hepatitis C virus
Ligand Molecules
Primary Citation

Abstact

A boronic acid moiety was found to be a critical pharmacophore for enhanced in vitro potency against wild-type hepatitis C replicons and known clinical polymorphic and resistant HCV mutant replicons. The synthesis, optimization, and structure-activity relationships associated with inhibition of HCV replication in a subgenomic replication system for a series of non-nucleoside boron-containing HCV RNA-dependent RNA polymerase (NS5B) inhibitors are described. A summary of the discovery of 3 (GSK5852), a molecule which entered clinical trials in subjects infected with HCV in 2011, is included.

Legend

Protein

Chemical

Disease

Primary Citation of related structures